Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1641)
Reports (63)
SAGE documentation (226)
Scientific publications (122)
Systematic reviews (SYSVAC) (3100)
Regions
Africa (297)
Americas (794)
Eastern Mediterranean (58)
Europe (744)
Global (1)
South-East Asia (82)
Western Pacific (216)
Diseases
Chikungunya (13)
Cholera (35)
COVID-19 (1589)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
5192 results found
2020
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine
2020
∙
Doran Fink
Update from the Vaccines and Related Biologics Products Advisory Committee (VRBPAC) Meeting of October 22, 2020
2020
∙
Megan Wallace, ACIP
Updates to COVID-19 Immunity and Epidemiology to Inform Vaccine Policy
2020
∙
Sarah Mbaeyi, ACIP
Use of mRNA COVID-19 Vaccines: Interim Clinical Considerations
2020
∙
ACIP, Sarah Mbaeyi
Use of Pfizer-BioNTech COVID-19 Vaccine: Clinical Considerations
2020
∙
ACIP
Vaccinate with Confidence for COVID-19 Vaccines
2020
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against seasonal influenza. Winter season 2020-2021
2020
∙
Conseil Supérieur de la Santé (CSS)
Vaccination Strategy against Covid-19 in Belgium
2020
∙
Haute Autorité de Santé
Vaccination strategy against COVID-19: Anticipation of possible vaccination scenarios and preliminary recommendations on target populations
2020
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Vaccination strategy against SARS-CoV-2 - the mRNA vaccine COMIRNATY® (BNT162b2)
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
